ATE299374T1 - Adenosine als antithrombosemittel - Google Patents

Adenosine als antithrombosemittel

Info

Publication number
ATE299374T1
ATE299374T1 AT01112092T AT01112092T ATE299374T1 AT E299374 T1 ATE299374 T1 AT E299374T1 AT 01112092 T AT01112092 T AT 01112092T AT 01112092 T AT01112092 T AT 01112092T AT E299374 T1 ATE299374 T1 AT E299374T1
Authority
AT
Austria
Prior art keywords
biologically active
extract
plant
novel method
active ingredients
Prior art date
Application number
AT01112092T
Other languages
English (en)
Inventor
Su-Chen Chang
Li-Wei Hsu
Original Assignee
Advanced Gene Technology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Gene Technology Corp filed Critical Advanced Gene Technology Corp
Application granted granted Critical
Publication of ATE299374T1 publication Critical patent/ATE299374T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT01112092T 2000-11-07 2001-05-29 Adenosine als antithrombosemittel ATE299374T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70830600A 2000-11-07 2000-11-07

Publications (1)

Publication Number Publication Date
ATE299374T1 true ATE299374T1 (de) 2005-07-15

Family

ID=24845266

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01110765T ATE299593T1 (de) 2000-11-07 2001-05-03 Verfahren zum screenen von pflanzenextrakten nach wirkstoffen
AT01112092T ATE299374T1 (de) 2000-11-07 2001-05-29 Adenosine als antithrombosemittel

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT01110765T ATE299593T1 (de) 2000-11-07 2001-05-03 Verfahren zum screenen von pflanzenextrakten nach wirkstoffen

Country Status (7)

Country Link
US (1) US20020082241A1 (de)
EP (2) EP1205754B1 (de)
CN (2) CN1352945A (de)
AT (2) ATE299593T1 (de)
AU (1) AU5178801A (de)
CA (1) CA2348845A1 (de)
DE (2) DE60111906D1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855343B2 (en) * 2002-05-21 2005-02-15 Advanced Gene Technology, Corp Method to ascertain the quality of herbs
CN106501415A (zh) * 2016-12-02 2017-03-15 丽珠集团丽珠制药厂 一种阿魏酸钠、阿司匹林、桂利嗪和维生素b1的含量测定方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770198A (en) * 1988-05-18 1998-06-23 The Research Foundation Of The State Of New York Platelet-specific chimeric 7E3 immunoglobulin
WO1991011458A1 (en) * 1990-02-02 1991-08-08 Genentech, Inc. CYCLIC PEPTIDES CONTAINING Arg-Gly-Asp FLANKED BY PROLINE
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
JP3002903B2 (ja) * 1991-04-09 2000-01-24 第一化学薬品株式会社 血管外血液の抗凝固・抗血小板剤組成物及びこれを用いる血小板活性化の分子マーカーの測定法
US6137002A (en) * 1993-07-22 2000-10-24 Eli Lilly And Company Glycoprotein IIb/IIIa antagonists
IL121272A (en) * 1997-07-10 2000-06-01 Can Fite Technologies Ltd Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
DE19802576B4 (de) * 1998-01-23 2004-10-28 Xerion Pharmaceuticals Ag Verfahren zur gleichzeitigen Identifizierung von Proteinen und ihren Bindungspartnern
US6713309B1 (en) * 1999-07-30 2004-03-30 Large Scale Proteomics Corporation Microarrays and their manufacture

Also Published As

Publication number Publication date
EP1205182B1 (de) 2005-07-13
ATE299593T1 (de) 2005-07-15
CN1353003A (zh) 2002-06-12
EP1205754A2 (de) 2002-05-15
EP1205754B1 (de) 2005-07-13
EP1205182A2 (de) 2002-05-15
CA2348845A1 (en) 2002-05-07
AU5178801A (en) 2002-05-09
DE60111906D1 (de) 2005-08-18
EP1205182A3 (de) 2002-09-04
DE60111905D1 (de) 2005-08-18
CN1352945A (zh) 2002-06-12
CN1220060C (zh) 2005-09-21
US20020082241A1 (en) 2002-06-27
EP1205754A3 (de) 2002-07-17

Similar Documents

Publication Publication Date Title
IS2508B (is) Mótefni gegn ED-B hneppinu í fíbrónektíni, smíði þeirra og notkanir
ATE340870T1 (de) Adressierbare protein arrays
ATE425989T1 (de) Proteinreinigungsverfahren
DE60226486D1 (de) Selbstanordnende moleküle
FI875732A0 (fi) Elektrokemoluminescens- analysfoerfaranden.
BR9910332A (pt) Polipeptìdio, composição, método para purificação de polipeptìdio a partir de uma composição e método para purificação de um anticorpo a partir de uma composição
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
DE69610716D1 (de) Topiramate-immunoassay, sowie analoge und antikörper
NO960924D0 (no) Analysesett
Klees et al. Laminin-5 activates extracellular matrix production and osteogenic gene focusing in human mesenchymal stem cells
ATE459716T1 (de) Zytokin zcyt018
ATE194339T1 (de) Verbesserte immunoessayreagenzien zum nachweis von kannabinoiden
Uraipong et al. 17β-Estradiol residues and estrogenic activities in the Hawkesbury River, Australia
DK0449269T3 (da) Fremgangsmåde til påvisning af proteiner indeholdende phosphoryleret tyrosin
DK0460190T3 (da) Fremgangsmåde til påvisning af maligne sygdomme
CN103900893A (zh) 富集乙酰化修饰的蛋白质的试剂盒及方法和应用
DE60111905D1 (de) Adenosine als Antithrombosemittel
DK1141026T3 (da) Sammensætninger og fremgangsmåder til frembringelse af monoklonale antistoffer repræsentative for en specifik celletype
ES2195033T3 (es) Iso-indolonas condensadas utilizadas como inhibidores de proteina quinasa c.
Colpaert et al. Tournaisian (Early Carboniferous) foraminifers of the Kuznetsk Basin (South-West Siberia, Russia)
DK0640145T3 (da) Måling af en enzymmarkør som en hjælp ved diagnose
Arai et al. A method for the rapid discovery of naturally occurring products by proteins immobilized on magnetic beads and reverse affinity chromatography
Caruso et al. Immunoassay methods of plant hormone analysis
Legrand et al. Two structural types of ciguatoxins involved on ciguatera fish poisoning in French Polynesia
EP1732880A4 (de) Assays für amphetamin und methamphetamin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties